Literature DB >> 25287429

Transplantation: rituximab induction for prevention of HLA-antibody rebound.

Puneet Sood1, Sundaram Hariharan1.   

Abstract

Desensitization therapy enables HLA-incompatible transplantation. However, desensitized patients have an increased risk of antibody-mediated rejection, and the presence of donor-specific antibodies (DSAs) is associated with poor outcomes. A new study has assessed the effect of rituximab induction on DSA production in kidney transplant recipients with high immunological risk.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25287429     DOI： 10.1038/nrneph.2014.179

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


  10 in total

1.  Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience.

Authors:  M-K Jin; J-H Cho; O Kwon; K-D Hong; J-Y Choi; S-H Yoon; S-H Park; Y-L Kim; C-D Kim
Journal:  Transplant Proc       Date:  2012-01       Impact factor: 1.066

2.  Changes in anti-HLA antibody titers more than 1 year after desensitization therapy with rituximab in living-donor kidney transplantation.

Authors:  Toshio Takagi; Hideki Ishida; Hiroki Shirakawa; Tomokazu Shimizu; Kazunari Tanabe
Journal:  Transpl Immunol       Date:  2010-06-22       Impact factor: 1.708

3.  Combined posttransplant prophylactic IVIg/anti-CD 20/plasmapheresis in kidney recipients with preformed donor-specific antibodies: a pilot study.

Authors:  Alexandre Loupy; Caroline Suberbielle-Boissel; Julien Zuber; Dany Anglicheau; Marc-Olivier Timsit; Frank Martinez; Eric Thervet; Patrick Bruneval; Dominique Charron; Gary S Hill; Dominique Nochy; Christophe Legendre
Journal:  Transplantation       Date:  2010-06-15       Impact factor: 4.939

4.  Perioperative mortality and long-term survival following live kidney donation.

Authors:  Dorry L Segev; Abimereki D Muzaale; Brian S Caffo; Shruti H Mehta; Andrew L Singer; Sarah E Taranto; Maureen A McBride; Robert A Montgomery
Journal:  JAMA       Date:  2010-03-10       Impact factor: 56.272

5.  Comorbidity burden and perioperative complications for living kidney donors in the United States.

Authors:  Jesse D Schold; David A Goldfarb; Laura D Buccini; James R Rodrigue; Didier A Mandelbrot; Emily L G Heaphy; Richard A Fatica; Emilio D Poggio
Journal:  Clin J Am Soc Nephrol       Date:  2013-09-26       Impact factor: 8.237

6.  Desensitization in HLA-incompatible kidney recipients and survival.

Authors:  Robert A Montgomery; Bonnie E Lonze; Karen E King; Edward S Kraus; Lauren M Kucirka; Jayme E Locke; Daniel S Warren; Christopher E Simpkins; Nabil N Dagher; Andrew L Singer; Andrea A Zachary; Dorry L Segev
Journal:  N Engl J Med       Date:  2011-07-28       Impact factor: 91.245

7.  Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation.

Authors:  Carmen Lefaucheur; Alexandre Loupy; Gary S Hill; Joao Andrade; Dominique Nochy; Corinne Antoine; Chantal Gautreau; Dominique Charron; Denis Glotz; Caroline Suberbielle-Boissel
Journal:  J Am Soc Nephrol       Date:  2010-07-15       Impact factor: 10.121

8.  Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation.

Authors:  C Lefaucheur; C Suberbielle-Boissel; G S Hill; D Nochy; J Andrade; C Antoine; C Gautreau; D Charron; D Glotz
Journal:  Am J Transplant       Date:  2007-12-19       Impact factor: 8.086

9.  Rituximab and intravenous immune globulin for desensitization during renal transplantation.

Authors:  Ashley A Vo; Marina Lukovsky; Mieko Toyoda; Jennifer Wang; Nancy L Reinsmoen; Chih-Hung Lai; Alice Peng; Rafael Villicana; Stanley C Jordan
Journal:  N Engl J Med       Date:  2008-07-17       Impact factor: 91.245

10.  A closer look at rituximab induction on HLA antibody rebound following HLA-incompatible kidney transplantation.

Authors:  Annette M Jackson; Edward S Kraus; Babak J Orandi; Dorry L Segev; Robert A Montgomery; Andrea A Zachary
Journal:  Kidney Int       Date:  2014-07-23       Impact factor: 10.612
  10 in total
  3 in total

1.  B cells in transplantation.

Authors:  Esme I Dijke; Jeffrey L Platt; Paul Blair; Menna R Clatworthy; Jignesh K Patel; A G Kfoury; Marilia Cascalho
Journal:  J Heart Lung Transplant       Date:  2016-02-12       Impact factor: 10.247

2.  Tailored immunosuppression after kidney transplantation - a single center real-life experience.

Authors:  Miriam Good-Weber; Malgorzata Roos; Thomas F Mueller; Barbara Rüsi; Thomas Fehr
Journal:  BMC Nephrol       Date:  2020-11-23       Impact factor: 2.388

3.  Antibody-Dependent NK Cell Activation Is Associated with Late Kidney Allograft Dysfunction and the Complement-Independent Alloreactive Potential of Donor-Specific Antibodies.

Authors:  Tristan Legris; Christophe Picard; Dilyana Todorova; Luc Lyonnet; Cathy Laporte; Chloé Dumoulin; Corinne Nicolino-Brunet; Laurent Daniel; Anderson Loundou; Sophie Morange; Stanislas Bataille; Henri Vacher-Coponat; Valérie Moal; Yvon Berland; Francoise Dignat-George; Stéphane Burtey; Pascale Paul
Journal:  Front Immunol       Date:  2016-08-11       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.